Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexander Everhart"'
Autor:
Khoa Vu, Jiani Zhou, Alexander Everhart, Nihar Desai, Jeph Herrin, Anupam B. Jena, Joseph S. Ross, Nilay D. Shah, Pinar Karaca-Mandic
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney disease (CKD) following
Externí odkaz:
https://doaj.org/article/1fc8a9da240844628e0105e561ecb6cc
Autor:
Jiani Zhou, Pinar Karaca-Mandic, Joseph S. Ross, Nihar R. Desai, Jeph Herrin, Khoa Vu, Nilay Shah, Alexander Everhart, Anupam B. Jena
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Nephrology
BMC Nephrology
Background Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney disease (CKD) following new clin
Autor:
Laura Barrie Smith, Dori A. Cross, Bethany Sheridan, Alexander Everhart, Hannah T. Neprash, Donna McAlpine
Publikováno v:
Medical Care. 59:62-66
Background Physicians' time with patients is a critical input to care, but is typically measured retrospectively through survey instruments. Data collected through the use of electronic health records (EHRs) offer an alternative way to measure visit
Autor:
Nihar R. Desai, Molly M. Jeffery, Nilay Shah, Laura Barrie Smith, Lucas Higuera, Pinar Karaca-Mandic, Joseph S. Ross, Bryan E. Dowd, Alexander Everhart, Anupam B. Jena, Jeph Herrin
Publikováno v:
Int J Health Econ Manag
High-quality health care not only includes timely access to effective new therapies but timely abandonment of therapies when they are found to be ineffective or unsafe. Little is known about changes in use of medications after they are shown to be in
Autor:
Pinar Karaca-Mandic, Nilay Shah, Jeph Herrin, Joseph S. Ross, Jiani Zhou, Khoa Vu, Nihar R. Desai, Alexander Everhart, Anupam B. Jena
Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney diseases (CKD) following new clinical evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a709498918de8447a81f9247fd82dfe4
https://doi.org/10.21203/rs.3.rs-329817/v1
https://doi.org/10.21203/rs.3.rs-329817/v1
Autor:
Anupam B. Jena, Laura Barrie Smith, Jeph Herrin, Nihar R. Desai, Molly M. Jeffery, Lucas Higuera, Nilay Shah, Bryan E. Dowd, Pinar Karaca-Mandic, Joseph S. Ross, Alexander Everhart
Publikováno v:
Health Serv Res
OBJECTIVE: To describe physicians’ variation in de‐adopting concurrent statin and fibrate therapy for type 2 diabetic patients following a reversal in clinical evidence. DATA SOURCES: We analyzed 2007‐2015 claims data from OptumLabs(®) Data Wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a501ff4ff1411f447e95d572f82dda21
https://europepmc.org/articles/PMC8522575/
https://europepmc.org/articles/PMC8522575/
Autor:
Molly M. Jeffery, Nancy E. Morden, Pinar Karaca-Mandic, Katrina Harper, Zachary Levin, Alexander Everhart, Ashwini Sankar
Publikováno v:
JAMA Network Open
This cohort study of health claims data examines trends in testosterone prescriptions for older men in the US following 2014 changes to the US Food and Drug Administration’s stance on testosterone’s effects and safety risks.
Publikováno v:
Journal for healthcare quality : official publication of the National Association for Healthcare Quality. 39(2)
Despite the Affordable Care Act's push to improve the coordination of care for patients with multiple chronic conditions, most measures of coordination quality focus on a specific moment in the care process (e.g., medication errors or transfer betwee